Mali-specific data on demographics, health risks, barriers to accessing care, pregnancy-related care, maternal death data, newborn/infant death data, national/provincial policies, and delivery capacity. Download in French.
Tag Archive for neonatal
Risk Factors for Pre-eclampsia and Eclampsia in Mozambique
Mozambique-specific data on demographics, health risks, barriers to accessing care, pregnancy-related care, maternal death data, newborn/infant death data, national/provincial policies, and delivery capacity.
Risk Factors for Pre-eclampsia and Eclampsia in Rwanda
Rwanda-specific data on demographics, health risks, barriers to accessing care, pregnancy-related care, maternal death data, newborn/infant death data, national/provincial policies, and delivery capacity.
Risk Factors for Pre-eclampsia and Eclampsia in Senegal
Senegal-specific data on demographics, health risks, barriers to accessing care, pregnancy-related care, maternal death data, newborn/infant death data, national/provincial policies, and delivery capacity. Download in French.
Risk Factors for Pre-eclampsia and Eclampsia in Tanzania
Tanzania-specific data on demographics, health risks, barriers to accessing care, pregnancy-related care, maternal death data, newborn/infant death data, national/provincial policies, and delivery capacity.
Risk Factors for Pre-eclampsia and Eclampsia in Uganda
Uganda-specific data on demographics, health risks, barriers to accessing care, pregnancy-related care, maternal death data, newborn/infant death data, national/provincial policies, and delivery capacity.
Risk Factors for Pre-eclampsia and Eclampsia in Zambia
This infographic provides data on risk factors, policies, health system capacity and community perceptions in Zambia that impact health-seeking behaviors during pregnancy, specifically related to pre-eclampsia and eclampsia.
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses
Obstetrics & Gynecology, 2016 Findings: Most women reported at least one symptom (gastrointestinal discomfort and unusual/excessive bleeding) during the course of the trial, not differing by treatment arm (74% low-dose aspirin compared with 73% placebo group. Symptoms were more commonly…
